Asymmetric Chemical Synthesis Methods via Cooperative Catalysis
Asymmetric Chemical Synthesis Methods via Cooperative Catalysis
批准号:
9355214
负责人:
Thomas Neil Snaddon
金额:
$29.72万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-20 至 2021-06-30
关键词:
AddressAdoptedAmmoniumArchitectureAreaBiologicalCarbonCatalysisChemicalsChemistryClinicalCommunitiesComplexDataDevelopmentDiseaseEstersEventGeneric DrugsGoalsHealthHumanIndole AlkaloidsLaboratoriesMedicineMethodsMolecularNaturePalladiumPreparationProtocols documentationReactionResearchTherapeutic AgentsTransition ElementsWorkbasechemical bondchemical reactionchemical synthesisdesigndriving forceenolateenzyme activityflexibilityinfancymetal complexmolecular assembly/self assemblynext generationnovel therapeuticsprogramsscaffoldsynergismtertiary aminetherapeutic development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
The straightforward laboratory preparation of structural motifs commonly found in therapeutic agents is a major
driving force in catalysis-based reaction design. In our laboratory we have adopted cooperative catalysis, an
approach that emulates mechanisms encountered in enzymatic activity. In such a regime, merges of two (or
more) simultaneous and complementary catalysis events are merged to forge a single chemical bond, via
hitherto inaccessible chemical reactivity. Despite the infancy of this area, it promises much for the design of
new, efficient and operationally trivial catalytic asymmetric reactions, and expedite the design, development
and manufacture of medicines to manage and treat diseases.
Based on exciting preliminary data we have obtained in the arena of cooperative catalysis, the program
detailed in this proposal will provide the scientific community with straightforward, reliable and flexible methods
for chemical synthesis This work will significantly impact human health and medicine by establishing routine
synthetic protocols for the preparation of valuable molecular scaffolds, which will contribute to the design and
development of new clinical agents.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金